Type-2-Diabetes: Canagliflozin reduces cardiovascular Risk

被引：0
|
作者：
Lichert, Frank
机构：
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2017年 / 142卷 / 22期
关键词：
D O I：
10.1056/NEJMoa.1611925
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1647 / 1647
页数：1
相关论文
共 50 条
  • [11] Canagliflozin reduces the Risk of Hyperkalemia in Patients with Type-2 Diabetes and Kidney Failure
    Franke, Katharina
    AKTUELLE KARDIOLOGIE, 2022, 11 (02) : 119 - 119
  • [12] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Fernandez-Balsells, M. Merce
    Sojo-Vega, Lidia
    Ricart-Engel, Wifredo
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (21): : 2098 - 2098
  • [13] Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
    Neal, Bruce
    Perkovic, Vlado
    Mahaffey, Kenneth W.
    de Zeeuw, Dick
    Fulcher, Greg
    Erondu, Ngozi
    Shaw, Wayne
    Law, Gordon
    Desai, Mehul
    Matthews, David R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07): : 644 - 657
  • [14] Canagliflozin and cardiovascular and renal events in type 2 diabetes
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2018, 130 (02) : 149 - 153
  • [15] Prediabetes or type-2-diabetes and cancer risk
    Scheruebl, Hans
    DIABETOLOGIE UND STOFFWECHSEL, 2022, 17 (06) : 462 - 471
  • [16] Colchicine reduces cardiovascular risk in people with type 2 diabetes
    Di Lellis, Maddalena Angela
    DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (03) : 172 - 172
  • [17] Influence of blood sugar lowering Strategies on cardiovascular Events in Type-2-Diabetes and the presence of Diabetes Risk
    Jecht, M.
    DIABETOLOGE, 2015, 11 (05): : 411 - 412
  • [18] Pioglitazone reduces cardiovascular risk in patients with type 2 diabetes
    Bierwirth, R. A.
    Dietlein, M.
    Franzen, C.
    Gruenerbel, A.
    Hofmann, C.
    Merke, J.
    Luebben, G.
    Karagiannis, E.
    DIABETOLOGE, 2008, 4 (07): : 542 - 548
  • [19] Type-2-Diabetes Less Alcohol, lower Diabetes Risk
    Lichert, Frank
    AKTUELLE ERNAHRUNGSMEDIZIN, 2016, 41 (03): : 164 - 164
  • [20] Sedentary Lifestyle as Risk Factor for Type-2-Diabetes
    Pavlicek, V.
    DIABETOLOGE, 2015, 11 (04): : 322 - 323
12345